PSY8 DIRECT AND INDIRECT COSTS OF PRIVATELY-INSURED PATIENTS TREATED WITH OXYMORPHONE EXTENDED-RELEASE OR OXYCODONE CONTROLLED-RELEASE TABLETS
May 1, 2011, 00:00
10.1016/j.jval.2011.02.341
https://www.valueinhealthjournal.com/article/S1098-3015(11)00480-3/fulltext
Title :
PSY8 DIRECT AND INDIRECT COSTS OF PRIVATELY-INSURED PATIENTS TREATED WITH OXYMORPHONE EXTENDED-RELEASE OR OXYCODONE CONTROLLED-RELEASE TABLETS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00480-3&doi=10.1016/j.jval.2011.02.341
First page :
A60
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
900